{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2012"],"condition":["Familial adenomatous polyposis","Cancer-Bowel-Back passage (rectum) or large bowel (colon)","Human Genetics and Inherited Disorders-Other human genetics and inherited disorders","Oral and Gastrointestinal-Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon","Adenomas incidence in rectal stumps and ileal pouches"],"disease":["Oral And Gastrointestinal-other Diseases Of The Mouth, Teeth, Oesophagus, Digestive System Including Liver And Colon","Adenomas Incidence In Rectal Stumps And Ileal Pouches","Human Genetics And Inherited Disorders-other Human Genetics And Inherited Disorders","Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)","Familial Adenomatous Polyposis"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2457717"],"location":["Portugal"],"study_start_month":["6"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Effect of topical mesalazine over adenomas incidence in rectal stumps and ileal pouches of familial adenomatous polyposis patients submitted to colectomy.","description":"Interventions: Mesalazine, 1g per day of rectal foam, for 12months\nPrimary outcome(s): New adenomas (larger than 5mm) incidence in the rectal stumps or ileal pouches, as assessed by endoscopy[At study entry and six and twelve months after mesalazine use]\nStudy Design: Purpose: Prevention; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Efficacy","dates":{"creation":"2012-06-15"},"accession":"2457717","cross_references":{"Australian New Zealand Clinical Trials Registry":["ACTRN12611001281987"]}}